Results 221 to 230 of about 3,831 (231)

Vaborbactam

RCSB Protein Data Bank
openaire   +1 more source

Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae

European Journal of Clinical Microbiology and Infectious Diseases, 2018
Young R Lee, Lee Young R
exaly  

Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2019
Mojgan Sabet, Ziad Tarazi, David C Griffith   +2 more
exaly  

Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model

Antimicrobial Agents and Chemotherapy, 2018
Mojgan Sabet, Ziad Tarazi, Jonathan Parkinson   +2 more
exaly  

Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

Antimicrobial Agents and Chemotherapy, 2018
Fekade B Šime, Saurabh Pandey, Suzanne L Parker   +2 more
exaly  

Pharmacokinetics of the Meropenem Component of Meropenem‐Vaborbactam in the Treatment of KPC‐Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient

Pharmacotherapy, 2018
Ishminder Kaur, Wayne S Moore, Arun Chopra   +2 more
exaly  

Cloxacillin/meropenem/vaborbactam

Reactions Weekly
openaire   +1 more source

In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China

Journal of Antimicrobial Chemotherapy, 2018
Menglan Zhou, Qiwen Yang, Olga Lomovskaya   +2 more
exaly  

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Clinical Infectious Diseases, 2019
Robert A Bonomo, , Pogue Jason M
exaly  

Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem

Antimicrobial Agents and Chemotherapy, 2019
David C Griffith, Mojgan Sabet, Ziad Tarazi   +2 more
exaly